camptothecin has been researched along with carbamates in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Aiyama, R; Furuta, T; Miyasaka, T; Nokata, K; Okajima, S; Sawada, S; Sugino, E; Yamaguchi, K; Yokokura, T | 1 |
Coy, DH; Fuselier, JA; Murphy, WA; Sun, L; Vasilevich, N; Woltering, SN | 1 |
Ast, G; Bowdish, K; Pessah, N; Reznik, M; Shabat, D; Shamis, M; Shomron, N; Xin, H; Yantiri, F | 1 |
Ieki, R; Iguchi, M; Kato, T; Okamura, T; Ota, T; Saito, E; Shibuya, M; Yuasa, K | 1 |
Coy, DH; Etienne, MA; Fuselier, JA; Kostochka, M | 1 |
Takane, H | 1 |
Ahn, JH; Boo, JH; Jeon, GS; Kang, DE; Kim, C; Kim, KH; Kim, YE; Mook-Jung, I; Ryu, H; Song, H | 1 |
Guo, N; Lv, J; Ma, MX; Teng, YO; Wen, SP; Yu, P | 1 |
Albeck, A; Firer, MA; Gellerman, G; Gilad, Y; Noy, E; Senderowitz, H | 1 |
Chen, B; Ma, H; Miao, Z; Wang, C; Wang, Y; Yao, J; Zhang, W | 1 |
1 review(s) available for camptothecin and carbamates
Article | Year |
---|---|
[Genetic polymorphisms of SLCO1B1 for drug pharmacokinetics and its clinical implications].
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents, Phytogenic; Camptothecin; Carbamates; Haplotypes; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Irinotecan; Liver; Liver-Specific Organic Anion Transporter 1; Organic Anion Transporters; Pharmacogenetics; Piperidines; Polymorphism, Genetic | 2011 |
9 other study(ies) available for camptothecin and carbamates
Article | Year |
---|---|
Synthesis and antitumor activity of 20(S)-camptothecin derivatives: carbamate-linked, water-soluble derivatives of 7-ethyl-10-hydroxycamptothecin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carbamates; Female; Irinotecan; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Solubility; Water | 1991 |
An adjustable release rate linking strategy for cytotoxin-peptide conjugates.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Bibenzyls; Camptothecin; Carbamates; Cross-Linking Reagents; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Neuroblastoma; Peptides; Rats; Somatostatin; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Bioactivation of carbamate-based 20(S)-camptothecin prodrugs.
Topics: Biotransformation; Camptothecin; Carbamates; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Growth Inhibitors; Humans; Prodrugs | 2004 |
A long-term survival case of small cell lung cancer in an HIV-infected patient.
Topics: Alkynes; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Benzoxazines; Camptothecin; Carbamates; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclopropanes; Didanosine; Dideoxynucleosides; Drug Administration Schedule; Furans; HIV Infections; HIV Long-Term Survivors; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Oxazines; Ritonavir; Sulfonamides; Tomography, X-Ray Computed | 2005 |
Synthesis of camptothecin-amino acid carbamate linkers.
Topics: Amino Acids; Camptothecin; Carbamates; Peptides; Prodrugs; Solid-Phase Synthesis Techniques | 2012 |
Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Apoptosis; Brain; Camptothecin; Carbamates; Cell Line; Dipeptides; DNA Damage; Gene Expression; Gene Knockout Techniques; HEK293 Cells; Humans; Leukemia, Promyelocytic, Acute; Mice; Nuclear Proteins; Presenilins; Promyelocytic Leukemia Protein; RNA Interference; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Transcription Factors; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Up-Regulation | 2013 |
Synthesis and antitumor activity evaluation of a novel series of camptothecin analogs.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Carbamates; Drug Screening Assays, Antitumor; Hep G2 Cells; HT29 Cells; Humans; K562 Cells; Molecular Structure; Topoisomerase I Inhibitors | 2013 |
Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carbamates; Cell Line, Tumor; Cell Proliferation; Chlorambucil; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Liver; Mice; Molecular Dynamics Simulation; Molecular Structure; Peptides, Cyclic; Structure-Activity Relationship | 2016 |
Design, Synthesis and Biological Activity of (20S,21S)-7-Cyclohexyl-21-fluorocamptothecin Carbamates as Potential Antitumor Agents.
Topics: Antineoplastic Agents; Camptothecin; Carbamates; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Structure-Activity Relationship | 2020 |